Academic Journal
Q1Progress in Neuro-Psychopharmacology and Biological Psychiatry
About Progress in Neuro-Psychopharmacology and Biological Psychiatry
Progress in Neuro-Psychopharmacology and Biological Psychiatry is a scholarly journal published by Elsevier Inc.. SCImago 2025 lists it in Q1, with an SJR of 1.502 and H-index of 165.
Coverage: 1982-2026. Research categories: Biological Psychiatry (Q1); Pharmacology (Q1).
Source-backed journal facts
Topics in published research
Neurotransmitter Receptor Influence on Behavior; Tryptophan and brain disorders; Neuroscience and Neuropharmacology Research; Schizophrenia research and treatment; Stress Responses and Cortisol; Bipolar Disorder and Treatment.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
4,380.00 USD; 4,100.00 EUR; 3,510.00 GBP; 543,250.00 JPY
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Reviews
Community Reviews
Version History
September 25, 2026 at 7:28 am
September 25, 2026